Crow Point Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-9
Closed -$14K 202
2018
Q1
$14K Sell
9
-27
-75% -$42K ﹤0.01% 249
2017
Q4
$33K Buy
+36
New +$33K 0.01% 231